Literature DB >> 22936427

Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper.

Christian Pristipino1, Gian Paolo Anzola, Luigi Ballerini, Antonio Bartorelli, Moreno Cecconi, Massimo Chessa, Andrea Donti, Achille Gaspardone, Giuseppe Neri, Eustaquio Onorato, Gualtiero Palareti, Serena Rakar, Gianluca Rigatelli, Gennaro Santoro, Danilo Toni, Gian Paolo Ussia, Roberto Violini.   

Abstract

OBJECTIVES: To organize a common approach on the management of patent foramen ovale (PFO) and cryptogenic stroke that may be shared by different specialists.
BACKGROUND: The management of PFO related to cryptogenic stroke is controversial, despite an increase in interventional closure procedures.
METHODS: A consensus statement was developed by approaching Italian national cardiological, neurological, and hematological scientific societies. Task force members were identified by the president and/or the boards of each relevant scientific society or working group, as appropriate. Drafts were outlined by specific task force working groups. To obtain a widespread consensus, these drafts were merged and distributed to the scientific societies for local evaluation and revision by as many experts as possible. The ensuing final draft, merging all the revisions, was reviewed by the task force and finally approved by scientific societies.
RESULTS: Definitions of transient ischemic attack and both symptomatic and asymptomatic cryptogenic strokes were specified. A diagnostic workout was identified for patients with candidate event(s) and patient foramen ovale to define the probable pathogenesis of clinical events and to describe individual PFO characteristics. Further recommendations were provided regarding medical and interventional therapy considering individual risk factors of recurrence. Finally, follow-up evaluation was appraised.
CONCLUSIONS: Available data provided the basis for a shared approach to management of cryptogenic ischemic cerebral events and PFO among different Italian scientific societies. Wider international initiatives on the topic are awaited.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 22936427     DOI: 10.1002/ccd.24637

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Response to letter regarding article, "Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials".

Authors:  David M Kent; Georgios D Kitsios; David E Thaler
Journal:  Stroke       Date:  2013-11-05       Impact factor: 7.914

2.  Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs.

Authors:  David E Thaler; Robin Ruthazer; Christian Weimar; Jean-Louis Mas; Joaquín Serena; Emanuele Di Angelantonio; Federica Papetti; Shunichi Homma; Heinrich P Mattle; Krassen Nedeltchev; Marie-Luise Mono; Cheryl Jaigobin; Patrik Michel; Mitchell S V Elkind; Marco R Di Tullio; Jennifer S Lutz; John Griffith; David M Kent
Journal:  Neurology       Date:  2014-06-13       Impact factor: 9.910

3.  Recurrent arterial ischemic strokes in a patient with patent foramen ovale and ductus arteriosus: Presentation of our management and review of the literature.

Authors:  Dimitrios Panagopoulos; Sofia Loukopoulou; Evangelos Karanasios; Nikolaos Eleftherakis
Journal:  Glob Cardiol Sci Pract       Date:  2019-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.